Oliver Lagore Vanvalin Investment Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55K | Buy |
|
|||||
|
2024
Q4 | $2.95K | Sell |
|
|||||
|
2024
Q3 | $5.4K | Hold |
|
|||||
|
2024
Q2 | $6.21K | Hold |
|
|||||
|
2024
Q1 | $7.84K | Hold |
|
|||||
|
2023
Q4 | $7.2K | Sell |
|
|||||
|
2023
Q3 | $27.8K | Sell |
|
|||||
|
2023
Q2 | $45.8K | Hold |
|
|||||
|
2023
Q1 | $36.9K | Sell |
|
|||||
|
2022
Q4 | $41.3K | Sell |
|
|||||
|
2022
Q3 | $135K | Sell |
|
|||||
|
2022
Q2 | $144K | Buy |
|
|||||
|
2022
Q1 | $74K | Buy |
|